A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: Sustained vascular response

Nitric Oxide - Biology and Chemistry

Volumn 27, Issue 3, 2012, Pages 150-160

  Nacharaju, Parimala ^a   Tuckman Vernon, Chaim ^a   Maier, Keith E ^a   Chouake, Jason ^b   Friedman, Adam ^a,b   Cabrales, Pedro ^c   Friedman, Joel M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Nanotechnology; Nitric oxide; RSNO; S nitroso N acetyl cysteine; S Nitrosoglutathione; Vasodilation

Indexed keywords

ACETYLCYSTEINE; NANOPARTICLE; S NITROSO N ACETYL CYSTEINE; S NITROSOTHIOL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HYDROGEL; MEAN ARTERIAL PRESSURE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ACETYLCYSTEINE; ANIMALS; BLOOD PRESSURE; CARBON DIOXIDE; CRICETINAE; DRUG CARRIERS; GLUTATHIONE; HEART RATE; HYDROGEL; MALE; MESOCRICETUS; NANOPARTICLES; OXYGEN; S-NITROSOGLUTATHIONE; S-NITROSOTHIOLS; VASODILATION;

EID: 84863755841     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2012.06.003     Document Type: Article

References (84)

1. A.R. Butler, F.W. Flitney, and D.L. Williams NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective Trends Pharmacol. Sci. 16 1995 18 22
2. K.A. Hanafy, J.S. Krumenacker, and F. Murad NO, nitrotyrosine, and cyclic GMP in signal transduction Med. Sci. Monit. 7 2001 801 819 (Pubitemid 32691766)
3. L.J. McDonald, and F. Murad Nitric oxide and cyclic GMP signaling Proc. Soc. Exp. Biol. Med. 211 1996 1 6
4. M.W. Radomski, R.M. Palmer, and S. Moncada Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets Br. J. Pharmacol. 92 1987 181 187 (Pubitemid 17134934)
5. M.A. Marletta, P.S. Yoon, R. Iyengar, C.D. Leaf, and J.S. Wishnok Macrophage oxidation of l-arginine to nitrite and nitrate: nitric oxide is an intermediate Biochemistry 27 1988 8706 8711 (Pubitemid 19008186)
6. J.B. Hibbs Jr., R.R. Taintor, Z. Vavrin, and E.M. Rachlin Nitric oxide: a cytotoxic activated macrophage effector molecule Biochem. Biophys. Res. Commun. 157 1988 87 94 (Pubitemid 19004828)
7. D.J. Stuehr, S.S. Gross, I. Sakuma, R. Levi, and C.F. Nathan Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide J. Exp. Med. 169 1989 1011 1020 (Pubitemid 19085836)
8. C.P. de Oliveira, F.I. Simplicio, V.M. de Lima, K. Yuahasi, F.P. Lopasso, V.A. Alves, D.S. Abdalla, F.J. Carrilho, F.R. Laurindo, and M.G. de Oliveira Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats World J. Gastroenterol. 12 2006 1905 1911
9. H. Rubbo, V. Darley-Usmar, and B.A. Freeman Nitric oxide regulation of tissue free radical injury Chem. Res. Toxicol. 9 1996 809 820
10. S.R. Jaffrey, and S.H. Snyder Nitric oxide: a neural messenger Annu. Rev. Cell Dev. Biol. 11 1995 417 440 (Pubitemid 26019610)
11. A. Friedman, and J. Friedman New biomaterials for the sustained release of nitric oxide: past, present and future Expert Opin. Drug Deliv. 6 2009 1113 1122
12. G.R. Thatcher An introduction to NO-related therapeutic agents Curr. Top. Med. Chem. 5 2005 597 601 (Pubitemid 41179722)
13. P.J. Henry, O.H. Drummer, and J.D. Horowitz S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators Br. J. Pharmacol. 98 1989 757 766 (Pubitemid 19269798)
14. E.A. Kowaluk, R. Poliszczuk, and H.L. Fung Tolerance to relaxation in rat aorta: comparison of an S-nitrosothiol with nitroglycerin Eur. J. Pharmacol. 144 1987 379 383 (Pubitemid 18019811)
15. K.F. Ricardo, S.M. Shishido, M.G. de Oliveira, and M.H. Krieger Characterization of the hypotensive effect of S-nitroso-N-acetylcysteine in normotensive and hypertensive conscious rats Nitric Oxide 7 2002 57 66 (Pubitemid 35007261)
16. J.N. Bates, M.T. Baker, R. Guerra Jr., and D.G. Harrison Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required Biochem. Pharmacol. 42 Suppl 1991 S157 S165
17. A.R. Butler, C. Glidewell, J. McGinnis, and W.I. Bisset Further investigations regarding the toxicity of sodium nitroprusside Clin. Chem. 33 1987 490 492 (Pubitemid 17157861)
18. G. Hagan, J. Pepke-Zaba, Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds, Expert Rev. Respir. Med. 5 (2011) 163-71.
19. A.R. Butler, and P. Rhodes Chemistry, analysis, and biological roles of S-nitrosothiols Anal. Biochem. 249 1997 1 9 (Pubitemid 27251935)
20. C.F. Lam, S. Sviri, K.F. Ilett, and P.V. van Heerden Inhaled diazeniumdiolates (NONOates) as selective pulmonary vasodilators Expert Opin. Investig. Drugs 11 2002 897 909 (Pubitemid 34732709)
21. C.M. Maragos, D. Morley, D.A. Wink, T.M. Dunams, J.E. Saavedra, A. Hoffman, A.A. Bove, L. Isaac, J.A. Hrabie, and L.K. Keefer Complexes of.NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects J. Med. Chem. 34 1991 3242 3247
22. C.M. Maragos, J.M. Wang, J.A. Hrabie, J.J. Oppenheim, and L.K. Keefer Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release Cancer Res. 53 1993 564 568 (Pubitemid 23059437)
23. A.J. Friedman, G. Han, M.S. Navati, M. Chacko, L. Gunther, A. Alfieri, and J.M. Friedman Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites Nitric Oxide 19 2008 12 20
24. G. Han, A.J. Friedman, and J.M. Friedman Nitric oxide releasing nanoparticle synthesis and characterization Methods Mol. Biol. 704 2011 187 195
25. P. Cabrales, G. Han, C. Roche, P. Nacharaju, A.J. Friedman, and J.M. Friedman Sustained release nitric oxide from long-lived circulating nanoparticles Free Radic. Biol. Med. 49 2010 530 538
26. P. Cabrales, G. Han, P. Nacharaju, A.J. Friedman, and J.M. Friedman Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide Am. J. Physiol. Heart Circ. Physiol. 300 2011 H49 H56
27. G. Han, M. Tar, D.S. Kuppam, A. Friedman, A. Melman, J. Friedman, and K.P. Davies Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction J. Sex. Med. 7 2010 224 233
28. A. Friedman, K. Blecher, D. Sanchez, C. Tuckman-Vernon, P. Gialanella, J.M. Friedman, L.R. Martinez, and J.D. Nosanchuk Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology Virulence 2 2011 217 221
29. A.J. Friedman, K. Blecher, D. Schairer, C. Tuckman-Vernon, P. Nacharaju, D. Sanchez, P. Gialanella, L.R. Martinez, J.M. Friedman, and J.D. Nosanchuk Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione Nitric oxide 25 2011 381 386
30. G. Han, L.R. Martinez, M.R. Mihu, A.J. Friedman, J.M. Friedman, and J.D. Nosanchuk Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection PLoS One 4 2009 e7804
31. M.R. Mihu, U. Sandkovsky, G. Han, J.M. Friedman, J.D. Nosanchuk, and L.R. Martinez The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections Virulence 1 2010 62 67
32. L.R. Martinez, G. Han, M. Chacko, M.R. Mihu, M. Jacobson, P. Gialanella, A.J. Friedman, J.D. Nosanchuk, and J.M. Friedman Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection J. Invest. Dermatol. 129 2009 2463 2469
33. D. Schairer, L. Martinez, K. Blecher, J. Chouake, P. Nacharaju, P. Gialanella, J.M. Friedman, J. Nosanchuk, and A. Friedman Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses Virulence 3 2012
34. H.H. Al-Sa'doni, and A. Ferro S-nitrosothiols as nitric oxide-donors: chemistry, biology and possible future therapeutic applications Curr. Med. Chem. 11 2004 2679 2690 (Pubitemid 39255556)
35. D.L. Diesen, D.T. Hess, and J.S. Stamler Hypoxic vasodilation by red blood cells: evidence for an S-nitrosothiol-based signal Circ. Res. 103 2008 545 553
36. M.W. Foster, D.T. Hess, and J.S. Stamler Protein S-nitrosylation in health and disease: a current perspective Trends Mol. Med. 15 2009 391 404
37. M.W. Foster, T.J. McMahon, and J.S. Stamler S-nitrosylation in health and disease Trends Mol. Med. 9 2003 160 168 (Pubitemid 36626705)
38. D. Giustarini, A. Milzani, R. Colombo, I. Dalle-Donne, and R. Rossi Nitric oxide and S-nitrosothiols in human blood Clin. Chim. Acta 330 2003 85 98 (Pubitemid 36287635)
39. J.S. Stamler, D.I. Simon, J.A. Osborne, M.E. Mullins, O. Jaraki, T. Michel, D.J. Singel, and J. Loscalzo S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds Proc. Natl. Acad. Sci. USA 89 1992 444 448
40. I. Hornyak, K. Marosi, L. Kiss, P. Grof, Z. Lacza, Increased stability of S-nitrosothiol solutions via pH modulations, Free Radic. Res. 46 (2012) 214-225.
41. T.M. Hu, and T.C. Chou The kinetics of thiol-mediated decomposition of S-nitrosothiols AAPS J. 8 2006 E485 E492
42. L. Grossi, and P.C. Montevecchi A kinetic study of S-nitrosothiol decomposition Chemistry 8 2002 380 387 (Pubitemid 34111077)
43. G. Richardson, and N. Benjamin Potential therapeutic uses for S-nitrosothiols Clin. Sci. (Lond) 102 2002 99 105 (Pubitemid 34177806)
44. B.T. Mellion, L.J. Ignarro, C.B. Myers, E.H. Ohlstein, B.A. Ballot, A.L. Hyman, and P.J. Kadowitz Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation Mol. Pharmacol. 23 1983 653 664 (Pubitemid 13089783)
45. H. Al-Sa'doni, and A. Ferro S-Nitrosothiols: a class of nitric oxide-donor drugs Clin. Sci. (Lond) 98 2000 507 520 (Pubitemid 30260999)
46. H.H. Al-Sa'doni, I.Y. Khan, L. Poston, I. Fisher, and A. Ferro A novel family of S-nitrosothiols: chemical synthesis and biological actions Nitric Oxide 4 2000 550 560 (Pubitemid 32053266)
47. L.J. Ignarro, H. Lippton, J.C. Edwards, W.H. Baricos, A.L. Hyman, P.J. Kadowitz, and C.A. Gruetter Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates J. Pharmacol. Exp. Ther. 218 1981 739 749 (Pubitemid 11005147)
48. M.H. Krieger, K.F. Santos, S.M. Shishido, A.C. Wanschel, H.F. Estrela, L. Santos, M.G. De Oliveira, K.G. Franchini, R.C. Spadari-Bratfisch, and F.R. Laurindo Antiatherogenic effects of S-nitroso-N-acetylcysteine in hypercholesterolemic LDL receptor knockout mice Nitric Oxide 14 2006 12 20 (Pubitemid 43063503)
49. J.A. Garcia, L. dos Santos, A.L. Moura, K.F. Ricardo, A.C. Wanschel, S.M. Shishido, R.C. Spadari-Bratfisch, H.P. de Souza, and M.H. Krieger S-nitroso-N-acetylcysteine (SNAC) prevents myocardial alterations in hypercholesterolemic LDL receptor knockout mice by antiinflammatory action J. Cardiovasc. Pharmacol. 51 2008 78 85
50. P. Nachuraju, A.J. Friedman, J.M. Friedman, and P. Cabrales Exogenous nitric oxide prevents cardiovascular collapse during hemorrhagic shock Resuscitation 82 2011 607 613
51. A. Colantuoni, S. Bertuglia, and M. Intaglietta Quantitation of rhythmic diameter changes in arterial microcirculation Am. J. Physiol. 246 1984 H508 H517
52. M. Sakata, A. Yoshida, and M. Haga Methemoglobin in blood as determined by double-wavelength spectrophotometry Clin. Chem. 28 1982 508 511 (Pubitemid 12145620)
53. A.J. Friedman, G. Han, M.S. Navati, M. Chacko, L. Gunther, A. Alfieri, and J.M. Friedman Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites Nitric Oxide 19 2008 12 20
54. F. Murad Cyclic guanosine monophosphate as a mediator of vasodilation J. Clin. Invest. 78 1986 1 5 (Pubitemid 16068173)
55. B. Lima, M.T. Forrester, D.T. Hess, and J.S. Stamler S-nitrosylation in cardiovascular signaling Circ. Res. 106 2010 633 646
56. J.C. Wanstall, K.L. Homer, and S.A. Doggrell Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets Curr. Vasc. Pharmacol. 3 2005 41 53 (Pubitemid 40089526)
57. A.M. Hamad, A. Clayton, B. Islam, and A.J. Knox Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function Am. J. Physiol. Lung Cell Mol. Physiol. 285 2003 L973 L983
58. G.P. Ahern, V.A. Klyachko, and M.B. Jackson CGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO Trends Neurosci. 25 2002 510 517 (Pubitemid 35246321)
59. B. Brune, S. Mohr, and U.K. Messmer Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways Rev. Physiol. Biochem. Pharmacol. 127 1996 1 30
60. F. Murad Nitric oxide and cyclic guanosine monophosphate signaling in the eye Can. J. Ophthalmol. 43 2008 291 294
61. G. Boerrigter, H. Lapp, and J.C. Burnett Modulation of cGMP in heart failure: a new therapeutic paradigm Handb. Exp. Pharmacol. 2009 485 506
62. N. Hogg The biochemistry and physiology of S-nitrosothiols Annu. Rev. Pharmacol. Toxicol. 42 2002 585 600 (Pubitemid 34160536)
63. M.P. Gordge, J.S. Hothersall, and A.A. Noronha-Dutra Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione Br. J. Pharmacol. 124 1998 141 148 (Pubitemid 28210053)
64. I.S. Severina, O.G. Bussygina, N.V. Pyatakova, I.V. Malenkova, and A.F. Vanin Activation of soluble guanylate cyclase by NO donors-S-nitrosothiols, and dinitrosyl-iron complexes with thiol-containing ligands Nitric Oxide 8 2003 155 163 (Pubitemid 36765448)
65. A.R. Butler, H.H. Al-Sa'doni, I.L. Megson, and F.W. Flitney Synthesis, decomposition, and vasodilator action of some new S-nitrosated dipeptides Nitric Oxide 2 1998 193 202 (Pubitemid 28399895)
66. E.A. Kowaluk, and H.L. Fung Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols J. Pharmacol. Exp. Ther. 255 1990 1256 1264
67. W.R. Mathews, and S.W. Kerr Biological activity of S-nitrosothiols: the role of nitric oxide J. Pharmacol. Exp. Ther. 267 1993 1529 1537 (Pubitemid 24068731)
68. V.S. Fernandes, A. Martinez-Saenz, P. Recio, A.S. Ribeiro, A. Sanchez, M.P. Martinez, A.C. Martinez, A. Garcia-Sacristan, L.M. Orensanz, D. Prieto, and M. Hernandez Mechanisms involved in the nitric oxide-induced vasorelaxation in porcine prostatic small arteries Naunyn Schmiedebergs Arch. Pharmacol. 384 2011 245 253
69. R. Priora, A. Margaritis, S. Frosali, L. Coppo, D. Summa, D. Di Giuseppe, C. Aldinucci, G. Pessina, A. Di Stefano, and P. Di Simplicio In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways Pharmacol. Res. 64 2011 289 297
70. J.S. Stamler S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups Curr. Top. Microbiol. Immunol. 196 1995 19 36
71. D.R. Arnelle, and J.S. Stamler NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation Arch Biochem Biophys 318 1995 279 285
72. D.T. Hess, A. Matsumoto, S.O. Kim, H.E. Marshall, and J.S. Stamler Protein S-nitrosylation: purview and parameters Nat. Rev. Mol. Cell Biol. 6 2005 150 166 (Pubitemid 40215810)
73. J.L. Alencar, I. Lobysheva, K. Chalupsky, M. Geffard, F. Nepveu, J.C. Stoclet, and B. Muller S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries J. Pharmacol. Exp. Ther. 307 2003 152 159 (Pubitemid 37151901)
74. A. Slivka, R. Chuttani, D.L. Carr-Locke, L. Kobzik, D.S. Bredt, J. Loscalzo, and J.S. Stamler Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans J. Clin. Invest. 94 1994 1792 1798
75. A.J. de Belder, R. MacAllister, M.W. Radomski, S. Moncada, and P.J. Vallance Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation Cardiovasc. Res. 28 1994 691 694 (Pubitemid 24199186)
76. B. Ramsay, M. Radomski, A. De Belder, J.F. Martin, and P. Lopez-Jaramillo Systemic effects of S-nitroso-glutathione in the human following intravenous infusion Br. J. Clin. Pharmacol. 40 1995 101 102
77. E.J. Langford, A.S. Brown, R.J. Wainwright, A.J. de Belder, M.R. Thomas, R.E. Smith, M.W. Radomski, J.F. Martin, and S. Moncada Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty Lancet 344 1994 1458 1460 (Pubitemid 24351699)
78. C. Lees, E. Langford, A.S. Brown, A. de Belder, A. Pickles, J.F. Martin, and S. Campbell The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia Obstet. Gynaecol. 88 1996 14 19 (Pubitemid 26197269)
79. U. Elkayam, M. Janmohamed, M. Habib, and P. Hatamizadeh Vasodilators in the management of acute heart failure Crit. Care Med. 36 2008 S95 S105
80. J.D. Kirk, J.T. Parissis, and G. Filippatos Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department Heart Fail. Clin. 5 2009 43 54
81. J.W. Park Dual role of S-nitrosocaptopril as an inhibitor of angiotensin-converting enzyme and a nitroso group carrier Biochem. Biophys. Res. Commun. 189 1992 206 210
82. T.P. Dasgupta, and D.V. Aquart Transfer of nitric oxide from nitrovasodilators to free thiols-evidence of two distinct stages Biochem. Biophys. Res. Commun. 335 2005 730 733 (Pubitemid 41188259)
83. L. Jia, and R.C. Blantz The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats Eur. J. Pharmacol. 354 1998 33 41 (Pubitemid 28410228)
84. D.Y. Tsui, A. Gambino, and J.C. Wanstall S-nitrosocaptopril: acute in-vivo pulmonary vasodepressor effects in pulmonary hypertensive rats J. Pharm. Pharmacol. 55 2003 1121 1125 (Pubitemid 36998653)